Posts

Impact of Anesthesia on ECT-Related Impairments in Global Cognitive Function in Patients With Treatment-Resistant Depression: Study From France

Image
Out on PubMed, from investigators in France, in JECT, is this study: Impact of Anesthesia on Electroconvulsive Therapy-Related Impairments in Global Cognitive Function in Patients With Treatment-Resistant Depression. Bernardoff L, Blay M, Thellier D, D'Amato T, Galvao F, Poulet E. J ECT. 2025 Feb 17. doi: 10.1097/YCT.0000000000001119. Online ahead of print. PMID:   39961035   The abstract is copied below: Introduction: Electroconvulsive therapy (ECT) in patients with treatment-resistant depression frequently leads to impairments in global cognitive function. Propofol and etomidate are the 2 most frequently used drugs for anesthetic induction during ECT. However, only few studies compared their differential impact on ECT-related impairments in global cognitive function. Methods: We studied retrospectively 75 patients hospitalized at Centre Hospitalier Le Vinatier (Bron, France) who met the DSM-V criteria for major depressive disorder and were treated with bilateral ECT to compa...
Post a Comment
Read more

Underutilization of ECT: A Call for Urgent Attention: Editorial in Indian Journal of Psychological Medicine

Image
 Out on PubMed, from a noted Indian ECT scholar, is this editorial: Underutilization of  Electroconvulsive  Therapy (ECT): A Call for Urgent Attention. Thirthalli J. Indian J Psychol Med. 2025 Feb 12:02537176251317677. doi: 10.1177/02537176251317677. Online ahead of print. PMID:  39957794 The editorial is here . And here: The case report that begins this editorial is one of the most compelling you will ever read. The ECT advocacy message of this editorial, likewise, is extremely well presented. Recognition that ECT education and training are woefully inadequate in India and around the world should be a wake up call. I recommend a full and careful read of this piece by all ECT health professionals. Kudos to Dr. Thirthalli for this impactful contribution to the ECT literature. (Please see also yesterday's blog post for a very similar message.)
Post a Comment
Read more

Recasting the Role of ECT and the ECT Practitioner: For Severe Illness, Not Necessarily TRD.

Image
 Out on PubMed, from international authors, is this LTE: Recasting the role of electroconvulsive therapy and the electroconvulsive therapy practitioner: For severe illness, not necessarily treatment-resistant depression. Espinoza RT,  Kellner CH , Sartorius A, Nordenskjöld A. J Psychopharmacol. 2025 Feb 16:2698811251319469. doi: 10.1177/02698811251319469. Online ahead of print. PMID:  39956784 The LTE is here . And here: In this LTE my colleagues and I make the case for ECT as a treatment for a range of severe and urgent psychiatric illnesses. I am so glad we got to say this in this way, particularly the part about ECT practitioners being specialists in severe illness. For the sake of responsible and rational patient care, it is important to fairly represent ECT and not to prematurely hype supposed replacements.
Post a Comment
Read more

Esketamine Alleviates Cognitive Impairment Induced by ECT in a Depression Rat Model Via the KLF4/p38 MAPK Pathway: Basic Science Study From China

Image
 Out on PubMed, from researchers in China, is this basic science study: Esketamine alleviates cognitive impairment signs induced by modified electroconvulsive therapy in a depression rat model via the KLF4/p38 MAPK pathway. Zhou X, Zhang L, Gao W, Li H, Guo Q, Dai J, Gao F, Wang L. J Affect Disord. 2025 Feb 10:S0165-0327(25)00200-9. doi: 10.1016/j.jad.2025.02.012. Online ahead of print. PMID:  39938694 The abstract is copied below: Background: Depression is a common and serious psychiatric disorder with significant impacts on individuals. Modified electroconvulsive therapy (MECT) is an established treatment for severe and treatment-resistant depression, but its cognitive side effects, particularly memory impairments, limit its use. Esketamine (ESK), an FDA-approved antidepressant, has shown neuroprotective effects. However, its role in mitigating MECT-induced cognitive deficits remains unexplored. This study investigates whether ESK could alleviate MECT-induced signs of cognit...
Post a Comment
Read more

ECT Referral Workshop for Depression: Assessing Patients and Addressing Stigma: New Curriculum From New Mexico

Image
 Out on PubMed, from authors in New Mexico, is this paper: Electroconvulsive  Therapy (ECT) Referral Workshop for Depression: Assessing Patients and Addressing Stigma. Haynes W, Miller J, Weidner P, Abbott C. MedEdPORTAL. 2025 Feb 11;21:11497. doi: 10.15766/mep_2374-8265.11497. eCollection 2025. PMID:  39935971   The abstract is copied below: Introduction: Electroconvulsive therapy (ECT) is an important somatic treatment in psychiatry with well-defined indications, strong evidence for a quick response, and established efficacy. Despite the benefits of ECT, it is underutilized and inequitably accessed by patients in the United States. Patient and provider lack of knowledge, misinformation, and negative attitudes perpetuated by bias and stigma towards ECT can be significant barriers to patients receiving ECT. Methods: We created a workshop to address these issues with Kern's six-step approach, using the affective context learning theory as a conceptual framework. Based...
Post a Comment
Read more

Electroconvulsive Therapy: A Scotland-Wide Naturalistic Study of 4826 Treatment Episodes.

Image
Out on PubMed, from investigators in Scotland, is this paper: Electroconvulsive Therapy: A Scotland-Wide Naturalistic Study of 4826 Treatment Episodes. Martin JL, Strawbridge RJ, Christmas D, Fleming M, Kelly S, Varveris D, Martin D. Biol Psychiatry Glob Open Sci. 2024 Dec 16;5(2):100434. doi: 10.1016/j.bpsgos.2024.100434. eCollection 2025 Mar. PMID:  39926701  The abstract is copied below: Background: Electroconvulsive therapy (ECT) is an effective treatment option for several psychiatric disorders, including treatment-resistant depression, but there are concerns about potential adverse effects, particularly on cognition. This study describes ECT response and side effects in the Scottish ECT Audit Network. Methods: Data collected from 4826 treatment episodes includes pre-ECT and post-ECT illness severity scores (Clinical Global Impression-Severity [CGI-S] and Montgomery-Åsberg Depression Rating Scale [MADRS]), diagnosis, age, sex, consent status, treatment year, treatment fre...
Post a Comment
Read more

OpenEvidence on Why ECT Is "Controversial"

Image
 I queried OE on "Why is ECT controversial?" I blog about this to continue  to remind readers to try out OpenEvidence regarding ECT topics. I think this is pretty good and somewhat nuanced. I worry a bit about the "ethical considerations" section, given that the ethical issues are not at all controversial, IMO. If there is, in fact, sloppiness in the informed consent process, then that should be improved. But generally, ECT is the most scrutinized and informed consented procedure in all of medicine; the new APA Task Force Report has a 13-page chapter (Chapter 10) devoted to consent.
Post a Comment
Read more